- Amini, L., Tehranian, N., Movahedian, M., Ramezani Tehrani, F. and Ziaee, S. (2015). Antioxidant and management of polycystic ovary syndrome in Iran. Iranian Journal of Reproductive Medicine, 13(1): 1-8.
- Behboodi, Z., Fereidooni, B., Saffari, M. and Montazeri, A. (2018). Polycystic ovary syndrome and its impact on Iranian women's quality of life: a population-based study BMC. Womens Health, 18(1): 164.
- Bahman, M., Hajimehdipoor, H., Afrakhteh, M., Bioos, S., Hashem-Dabaghian, F. and Tansaz, M. (2018). The importance of sleep hygiene in polycystic ovary syndrome from the view of Iranian Traditional Medicine and Modern Medicine. International Journal of Preventive Medicine, 12(9): 87.
- Belgorosky, A., Guercio, G., Pepe, C., Saraco, N. and Rivarola, M.A. (2009). Genetic and clinical spectrum of aromatase deficiency in infancy. Childhood and adolescence. Hormone Research in Paediatrics, 72(6): 321-330.
- Chandirasegaran, G., Elanchezhiyan, C. and Ghosh, K. (2018). Effects of Berberine chloride on the liver of streptozotocin-induced diabetes in albino Wistar rats. Biomedicine and Pharmacotherapy, 99(10): 227-236.
- Davasaztabrizi, A. and Mehrani, K. (2017). Correlation of serum levels of T3 and T4 during the dry and postpartum periods with ovarian rebound in primiparous and multiparous cows. Journal of Veterinary Clinical Pathology, 11(41): 63-70. [In Persian]
- Di pietro, M., Abramovich, D., Parborell, F. and Pascuali, N. (2018). Ovarian angiogenesis in polycystic ovary syndrome. Reproduction, 155(5): 199-209.
- Firouzi, S. and Malekahmadi, M. (2018). Barberine in the treatment of obesity and metabolic syndrome: possible mechanisms of action. Diabetes, Metabolic Syndrome and Obesity, 8(11): 699-705.
- Gadalla, M.A., Huang, S., Wang, R., Norman, R.J., Abdullah, S.A., El Saman, A.M., et al. (2018). Effect of clomiphene citrate on endometrial thickness, ovulation, pregnancy and live birth in anovulatory women: systematic review and meta-analysis. Ultrasound in Obstetrics & Gynecology, 51(1): 64-76.
- Gonzalez, F. (2012). Inflammation in polycystic ovary syndrome underpinning of insulin resistance and ovarian dysfunction. Medicina Intensiva, 77(4): 300-305.
- Ghanbari, F., Shiravi, A., Molzemi, S. and Kalalian Moghadda, H. (2012). Effect of berberine hydrochloride on testicular damage in streptozotocin-induced diabetic rats. International Journal of Environmental Research and Public Health, 7(3): 129-135.
- Hassani-Bafrani, H., Najaran, H., Razi, M. and Rashtbari, H. (2019). Berberine ameliorates experimental varicocele-induced damages at testis and sperm levels; evidences for oxidative stress and inflammation. Dalton Trans, 51(2): 497-485.
- Kaveh, A., Haghdoust, R. and Mosaferi, S. (2015). Comparison between epidural injection of calcium–naloxone and intramuscular GnRH as therapeutic methods in the treatment of follicular ovarian cysts in dairy cattle. Journal of Veterinary Clinical Pathology, 2(30): 435-444. [In Persian]
- Kalhori, Z., Soleimani Mehranjani, M., Azadbakht, M. and shariaatzadeh, M.A. (2018). Ovary stereological features and serum biochemical factors following induction of polycystic ovary syndrome with testosterone enanthate in mice: an experimental study. International Journal of Reproductive BioMedicine, 16(4): 267-274.
- Li, MF., Zhou, X.M. and Li, X.L. (2018). The effect of berberine on polycystic ovary syndrome patients with insulin resistance (PCOS-IR): A meta-analysis and systematic review. Evidence-Based Complementary and Alternative Medicine, 32(5): 253-261.
- Marshall, K. (2001). Polycystic ovary syndrome: clinical consideration. Alternative Medicine Review, 6(3): 272-292.
- Mohajeri, D., Mousavi, G., Kaffashielahi, R. and Neshatgharamalek, M. (2017). Study on protective effect of naringenin (Citrus flavonone) on incipient diabetic hepatopathy in alloxan-induced diabetic rats. Journal of Veterinary Clinical Pathology, 1(37): 39-52. [In Persian]
- Qadri, S., Hussain, A. and Bhat, M.H. (2018). Polycystic ovary syndrome in bipolar affective disorder: a hospital-based study. Indian Journal of Psychological Medicine, 40(2): 121-128.
- Saleh, S. R, Attia, R. and Ghareeb, D. (2018). The ameliorating effect of berberine-rich fraction against gossypol-induced testicular inflammation and oxidative stress. International Journal of Women's Health, 3(10): 1056-1061.
- Wang, H.S. and Wang, T.H. (2003). Polycystic ovary syndrome insulin resistance and insulin like growth factors, IGF binding proteins. Chang Gung Medical Journal, 26(8): 540-553.
- Tabeshpour, J., Imenshahidi, M. and Hosseinzadeh, H. (2017). A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome. Iranian Journal of Basic Medical Sciences, 20(5): 557-568.
- Zan, Y., Kuai, C.X., Qiu, Z.X. and Huang, F. (2017). Berberine ameliorates diabetic neuropathy: TRPV1 modulation by PKC pathway. The American Journal of Chinese Medicine, 45(8): 1709-1723.
- Zhifang, X., Wei, F., Qian, S., Nannan, Y.U., Kun, Y.U., Shenjun, W., et al. (2017). Rhizoma Coptidis and berberine as a natural drug to combat aging and aging-related diseases via anti-oxidation and AMPK activation. Aging and Disease, 8(6): 760-777.
|
